Valeant to expand B+L manufacturing facility, add 120 new jobs

September 16, 2014

Valeant Pharmaceuticals International recently hosted a ribbon-cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY.

Laval, Quebec-Valeant Pharmaceuticals International recently hosted a ribbon-cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY.

More in this issue: Alphaeon to acquire Clarion Medical Technologies

The ceremony recognized the expansion and installation of the new manufacturing lines, which will produce the company's silicone hydrogel contact lens, Bausch + Lomb ULTRA. The solar array, which is currently under construction, will generate and supply electricity through the installation of 3,667 solar panels, helping to reduce the facility's carbon footprint by 800 tons of carbon dioxide emissions annually, according to Valeant.

"Our Rochester facility is a very important piece of our strategy to rebuild Bausch + Lomb as one of the leading contact lens producers," said J. Michael Pearson, chairman and chief executive officer of Valeant.  "Our Rochester Optics Center is a first in class manufacturing site for contact lens manufacturing and distribution, and with the new contact lens manufacturing lines, we will add much needed production capacity to supply both current and future demand.”

The facility’s expansion will include 120 newly-hired workers.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.